Research graph
References from Cognition, schizophrénie et effet des antipsychotiques : le point de vue d’un laboratoire de recherche clinique. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
1986 · External reference
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
10.1176/appi.ajp.159.6.1018 · 2002 · External reference
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug
1997 · External reference
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine
10.1016/s0140-6736(95)90441-7 · 1995 · External reference
Neural substrates of sadness in schizophrenia: an f MRI study International
2002 · External reference
Cognitive dysfunction in schizophrenia: a new set of tools for the assessment of cognition and drug effects
10.1111/j.1600-0447.1999.tb05991.x · 1999 · External reference
Atypical anti-psychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
10.1136/bmj.321.7273.1371 · 2000 · External reference
Learning and memory in monozygotic twins discordant for schizophrenia
10.1017/s0033291700038861 · 1993 · External reference
Thought disorder, working memory and attention: interrelationships and the effects of neuroleptic medications
1995 · External reference
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the «right stuff»?
10.1093/oxfordjournals.schbul.a033430 · 2000 · External reference
The neurocognitive effects of low-dose halopéridol: a two-year comparison with risperidone
10.1016/s0006-3223(02)01370-7 · 2002 · External reference
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
10.1016/j.biopsych.2004.06.023 · 2004 · External reference
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study
10.1007/s00213-002-1342-5 · 2003 · External reference
Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior
10.1001/archpsyc.61.9.866 · 2004 · External reference
Cognitive effects and antipsychotic treatment
10.1016/s0306-4530(02)00115-4 · 2003 · External reference
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol
10.1176/appi.ajp.161.6.985 · 2004 · External reference
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis
10.1093/oxfordjournals.schbul.a033374 · 1999 · External reference
Validation of a bio-psycho-social model of adaptation for people with schizophrenia The VIIIth International Congress on schizophrenia
2001 · External reference
The symptoms of chronic schizophrenia A re-examination of the positive-negative dichotomy
10.1192/bjp.151.2.145 · 1987 · External reference
Patterns of cerebral blood flow in schizophrenia
10.1192/bjp.160.2.179 · 1992 · External reference
Memory and attention deficits in drug naive patients with schizophrenia
10.1016/s0920-9964(00)00102-x · 2001 · External reference
Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia
10.1176/jnp.11.4.481 · 1999 · External reference
Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia
10.1016/j.schres.2004.09.010 · 2004 · External reference
The effects of clozapine on cognitive functioning in schizophrenia
1999 · External reference
The role of serotonin in antipsychotic drug action
10.1016/s0893-133x(99)00046-9 · 1999 · External reference
Changes in distributed neural circuitry function in patients with first-episode schizophrenia
10.1192/bjp.185.3.205 · 2004 · External reference
The crucial role of sustained attention in community functioning in outpatients with schizophrenia
10.1016/j.psychres.2004.07.005 · 2004 · External reference
Cognitive improvement in schizophrenia with novel antipsychotic medications
10.1016/s0920-9964(98)00166-2 · 1999 · External reference
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol The Canadian Collaborative Group for research in schizophrenia
10.1001/archpsyc.57.3.249 · 2000 · External reference
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol
10.1007/s00213-003-1505-z · 2003 · External reference
Assessment of daily activities in young adults with schizophrenia
2004 · External reference
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
10.1007/bf02245606 · 1996 · External reference
Assessment of executive dysfunction during activities of daily living in schizophrenia
10.1016/j.schres.2003.07.005 · 2004 · External reference
Behavioral disorganization in schizophrenia during a daily activity: the kitchen behavioral scoring scale
10.1006/brcg.2001.1415 · 2002 · External reference
Impact on cognition of the use of antipsychotics
10.1185/030079902125001074 · 2002 · External reference
Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia
10.1007/s00213-003-1506-y · 2003 · External reference
Structure and function of declarative and nondeclarative memory systems
10.1073/pnas.93.24.13515 · 1996 · External reference
La schizophrénie
2005 · External reference
Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia
10.1016/s0010-440x(03)00086-5 · 2003 · External reference
Does blunted affect in schizophrenia improve with quetiapine? A functional magnetic resonance imaging study
2002 · External reference
The effect of risperidone on cognition in patients with schizophrenia
10.1177/070674379604100802 · 1996 · External reference
A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine
10.1097/01.jcp.0000085414.08426.8f · 2003 · External reference
Environmental cognitive remediation in schizophrenia: ethical implications of «Smart Home» technology
10.1177/070674370505000509 · 2004 · External reference
Does cognitive function improve with quetiapine in comparison to halopéridol?
10.1016/s0920-9964(01)00268-7 · 2002 · External reference
